Crossmark

Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation

Crossref DOI link: https://doi.org/10.1038/s41419-020-02907-x

Published Online: 2020-08-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Noman, Abu Shadat M.

Parag, Rashed R.

Rashid, Muhammad I.

Islam, Shafiqul

Rahman, Mohammad Z.

Chowdhury, Ali A.

Sultana, Afrin

Jerin, Chandsultana

Siddiqua, Ayesha

Rahman, Lutfur

Nayeem, Junayed

Akther, Sonam

Baidya, Sunanda

Shil, Rajib K.

Rahman, Mizanur

Shirin, Afsana

Mahmud, Reaz

Hossain, S. M. Ikram

Sumi, Sharmin A.

Chowdhury, Arfina

Basher, Shabnam B.

Hasan, Abul

Bithy, Shammy

Aklima, Jannatul

Chowdhury, Nabila

Hasan, Muhammad N.

Banu, Tahmina

Chowdhury, Srikanta

Hossain, Muhammad M.

Yeger, Herman

Farhat, Walid A.

Islam, Syed S. https://orcid.org/0000-0003-2201-8642
License Information

Text and Data Mining valid from 2020-08-20

Version of Record valid from 2020-08-20
More Information

Article History

Received: 20 February 2020

Revised: 5 August 2020

Accepted: 5 August 2020

First Online: 20 August 2020

Conflict of interest

: The authors declare that they have no conflict of interest.

: The research was reviewed and approved by the Ethics Committee of Bangladesh Medical Research Council (BMRC) (approval ID 052(l) 04 06 2014).

: Informed consent was obtained from all participating individuals in the study in agreement with institutional guidelines.

Document is current

Any future updates will be listed below